申请人:Martin-Luther-Universität Halle-Wittenberg
公开号:EP4008716A1
公开(公告)日:2022-06-08
The presented invention provides compounds of formula (I),
or a pharmaceutically acceptable salt, solvate or polymorph thereof, including all tautomers and stereoisomers thereof, wherein W, X, Y, Z, m, n and o are as defined herein. Said compounds of formula (I) are inhibitors of insulin-like growth factor 2 mRNA binding proteins (IGF2BP). Provided are novel inhibitors of IGF2BPs and processes for manufacturing the same. Efficacy of the new compounds is shown in solid cancer models.
本发明提供了式 (I) 的化合物、
或其药学上可接受的盐、溶液或多晶型物,包括其所有同系物和立体异构体,其中 W、X、Y、Z、m、n 和 o 如本文所定义。所述式(I)化合物是胰岛素样生长因子 2 mRNA 结合蛋白(IGF2BP)的抑制剂。本文提供了新型 IGF2BPs 抑制剂及其生产工艺。在实体癌模型中显示了新化合物的功效。